Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000421443 | SCV000519721 | benign | not specified | 2016-03-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001273269 | SCV001730410 | benign | Hereditary spastic paraplegia 49 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001273269 | SCV001755028 | benign | Hereditary spastic paraplegia 49 | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000421443 | SCV002050719 | likely benign | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004703938 | SCV005211474 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001273269 | SCV001456116 | benign | Hereditary spastic paraplegia 49 | 2020-09-16 | no assertion criteria provided | clinical testing |